Starling Oncology, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery
Starling Oncology, Inc. (DFPH) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $105.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2022-08-09
- Starling Oncology, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2022-06-30 was $105.00K, a 85.46% decline year-over-year.
- Starling Oncology, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2022-03-31 was $23.00K.
- Starling Oncology, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2021-06-30 was $722.00K.
- Starling Oncology, Inc. accounts receivable, allowance for credit loss, recovery for the quarter ending 2021-03-31 was $0.00.
- Starling Oncology, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2021 was $465.00K.
- Starling Oncology, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2020 was $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|---|---|
| 2022-06-30 | $105.00K 10-Q · filed 2022-08-09 | $82.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $23.00K 10-Q · filed 2022-05-10 | ||
| 2021-12-31 | $465.00K 10-K · filed 2022-03-11 | ||
| 2021-06-30 | $722.00K 10-Q · filed 2022-08-09 | $722.00K 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |